menu
    • menu

    Company profile for EvolveImmune Therapeutics

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bold Science. Better Outcomes. At EvolveImmune, we harness our “Immunology First” approach to create first-in-category cancer medicines to transform the lives of patients by delivering superior, long-term outcomes compared to current anti-cancer therapies. We are pioneers who rapidly translate discoveries into innovations and innovations into differentiated therapeutic solutions, to address the most significant unme...
    Bold Science. Better Outcomes. At EvolveImmune, we harness our “Immunology First” approach to create first-in-category cancer medicines to transform the lives of patients by delivering superior, long-term outcomes compared to current anti-cancer therapies. We are pioneers who rapidly translate discoveries into innovations and innovations into differentiated therapeutic solutions, to address the most significant unmet medical needs in oncology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EvolveImmune TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    23 Business Park Drive Branford, CT 06405
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://evolveimmune.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/evolveimmune-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EvolveImmune Hits Preclinical Milestone with AbbVie
    EvolveImmune Hits Preclinical Milestone with AbbVie

    28 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/28/3282438/0/en/evolveimmune-therapeutics-announces-achievement-of-preclinical-milestone-in-collaboration-with-abbvie.html

    GLOBENEWSWIRE
    28 Apr 2026
    Share Share
    EvolveImmune to Present EVOLVE104, EVOLVE Data at 2026 Conference
    EvolveImmune to Present EVOLVE104, EVOLVE Data at 2026 Conference

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273185/0/en/EvolveImmune-Therapeutics-to-Present-Update-on-Lead-Asset-EVOLVE104-and-New-Data-for-EVOLVE-T-Cell-Engager-Platform-at-2026-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    Evolveimmune Initiates Phase 1 Trial Of EVOLVE104 In Solid Tumors
    Evolveimmune Initiates Phase 1 Trial Of EVOLVE104 In Solid Tumors

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206091/0/en/EvolveImmune-Therapeutics-Announces-Initiation-of-Dosing-in-a-Phase-1-Trial-of-EVOLVE104-in-Patients-with-Solid-Tumors.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    EvolveImmune's EVOLVE104 Trispecific T Cell Engager FDA Cleared
    EvolveImmune's EVOLVE104 Trispecific T Cell Engager FDA Cleared

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133320/0/en/EvolveImmune-Therapeutics-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-EVOLVE104-a-Novel-Trispecific-T-Cell-Engager-with-Integrated-CD2-Costimulation.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    EvolveImmune Therapeutics Collaborates on Tumor Target Study
    EvolveImmune Therapeutics Collaborates on Tumor Target Study

    08 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/08/3057460/0/en/EvolveImmune-Therapeutics-Announces-Translational-Research-Collaboration-to-Evaluate-Expression-of-Novel-Tumor-Target-in-Muscle-Invasive-Bladder-Cancer.html

    GLOBENEWSWIRE
    08 Apr 2025
    Share Share
    EvolveImmune Appoints Kristen M. Hege to Its Board of Directors
    EvolveImmune Appoints Kristen M. Hege to Its Board of Directors

    11 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/11/3024112/0/en/EvolveImmune-Appoints-Kristen-M-Hege-M-D-to-Its-Board-of-Directors.html

    GLOBENEWSWIRE
    11 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search